Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.02 AUD | 0.00% | -16.67% | +81.82% |
Mar. 13 | Australian Shares Track Gains of Wall Street Peers as Market Shrugs Off US Inflation Data | MT |
Mar. 13 | LBT Innovations' APAS PharmaQC Completes Primary Validation; Shares Up 79% | MT |
Sales 2022 | 2.13M 1.37M | Sales 2023 | 2.13M 1.37M | Capitalization | 10.37M 6.69M |
---|---|---|---|---|---|
Net income 2022 | -6M -3.87M | Net income 2023 | -22M -14.19M | EV / Sales 2022 | 12.4 x |
Net Debt 2022 | 1.5M 967K | Net Debt 2023 | 1.37M 881K | EV / Sales 2023 | 5.51 x |
P/E ratio 2022 |
-3.58
x | P/E ratio 2023 |
-0.44
x | Employees | 19 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 62.72% |
Latest transcript on LBT Innovations Limited
1 week | -16.67% | ||
Current month | -16.67% | ||
1 month | -23.08% | ||
3 months | +53.85% | ||
6 months | +233.33% | ||
Current year | +81.82% |
Managers | Title | Age | Since |
---|---|---|---|
Brenton Barnes
CEO | Chief Executive Officer | - | 16-08-07 |
Raymond Ridge
DFI | Director of Finance/CFO | - | 17-08-24 |
Rhys Hill
CTO | Chief Tech/Sci/R&D Officer | - | 17-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel L. Hill
DFI | Director of Finance/CFO | - | 14-08-24 |
Brenton Barnes
CEO | Chief Executive Officer | - | 16-08-07 |
Rebecca Wilson
CHM | Chairman | - | 23-06-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-17 | 0.02 | 0.00% | 629,188 |
24-04-16 | 0.02 | 0.00% | 1,545,429 |
24-04-15 | 0.02 | -4.76% | 2,264,605 |
24-04-12 | 0.021 | 0.00% | 437,440 |
24-04-11 | 0.021 | -12.50% | 2,584,949 |
Delayed Quote Australian S.E., April 17, 2024 at 02:10 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+81.82% | 17.17M | |
-1.78% | 41.36B | |
+47.70% | 41.3B | |
+4.01% | 39.61B | |
-15.14% | 25.62B | |
+3.16% | 24.09B | |
-24.08% | 18.38B | |
-2.67% | 11.82B | |
+24.76% | 11.85B | |
+7.01% | 11.07B |
- Stock Market
- Equities
- LBT Stock